Cargando…
Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma
Y-Box Binding protein 1 (YBX-1) is known to be involved in various types of cancers. It's interactors also play major role in various cellular functions. Present work aimed to study the expression profile of the YBX-1 interactors during lung adenocarcinoma (LUAD). The differential expression an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030768/ https://www.ncbi.nlm.nih.gov/pubmed/29973960 http://dx.doi.org/10.7150/jgen.20581 |
_version_ | 1783337189671698432 |
---|---|
author | Murugesan, Suriya Narayanan Yadav, Birendra Singh Maurya, Pramod Kumar Chaudhary, Amit Singh, Swati Mani, Ashutosh |
author_facet | Murugesan, Suriya Narayanan Yadav, Birendra Singh Maurya, Pramod Kumar Chaudhary, Amit Singh, Swati Mani, Ashutosh |
author_sort | Murugesan, Suriya Narayanan |
collection | PubMed |
description | Y-Box Binding protein 1 (YBX-1) is known to be involved in various types of cancers. It's interactors also play major role in various cellular functions. Present work aimed to study the expression profile of the YBX-1 interactors during lung adenocarcinoma (LUAD). The differential expression analysis involved 57 genes from 95 lung adenocarcinoma samples, construction of gene network and topology analysis. A Total of 43 genes were found to be differentially expressed from which 17 genes were found to be down regulated and 26 genes were up-regulated. We observed that Polyadenylate-binding protein 1 (PABPC1), a protein involved in YBX1 translation, is highly correlated with YBX1. The interaction network analysis for a differentially expressed non-coding RNA Growth Arrest Specific 5 (GAS5) suggests that two proteins namely, Growth Arrest Specific 2 (GAS2) and Peripheral myelin protein 22 (PMP22) are potentially involved in LUAD progression. The network analysis and differential expression suggests that Collagen type 1 alpha 2 (COL1A2) can be potential biomarker and target for LUAD. |
format | Online Article Text |
id | pubmed-6030768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-60307682018-07-04 Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma Murugesan, Suriya Narayanan Yadav, Birendra Singh Maurya, Pramod Kumar Chaudhary, Amit Singh, Swati Mani, Ashutosh J Genomics Research Paper Y-Box Binding protein 1 (YBX-1) is known to be involved in various types of cancers. It's interactors also play major role in various cellular functions. Present work aimed to study the expression profile of the YBX-1 interactors during lung adenocarcinoma (LUAD). The differential expression analysis involved 57 genes from 95 lung adenocarcinoma samples, construction of gene network and topology analysis. A Total of 43 genes were found to be differentially expressed from which 17 genes were found to be down regulated and 26 genes were up-regulated. We observed that Polyadenylate-binding protein 1 (PABPC1), a protein involved in YBX1 translation, is highly correlated with YBX1. The interaction network analysis for a differentially expressed non-coding RNA Growth Arrest Specific 5 (GAS5) suggests that two proteins namely, Growth Arrest Specific 2 (GAS2) and Peripheral myelin protein 22 (PMP22) are potentially involved in LUAD progression. The network analysis and differential expression suggests that Collagen type 1 alpha 2 (COL1A2) can be potential biomarker and target for LUAD. Ivyspring International Publisher 2018-06-26 /pmc/articles/PMC6030768/ /pubmed/29973960 http://dx.doi.org/10.7150/jgen.20581 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Murugesan, Suriya Narayanan Yadav, Birendra Singh Maurya, Pramod Kumar Chaudhary, Amit Singh, Swati Mani, Ashutosh Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma |
title | Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma |
title_full | Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma |
title_fullStr | Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma |
title_full_unstemmed | Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma |
title_short | Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma |
title_sort | expression and network analysis of ybx1 interactors for identification of new drug targets in lung adenocarcinoma |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030768/ https://www.ncbi.nlm.nih.gov/pubmed/29973960 http://dx.doi.org/10.7150/jgen.20581 |
work_keys_str_mv | AT murugesansuriyanarayanan expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma AT yadavbirendrasingh expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma AT mauryapramodkumar expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma AT chaudharyamit expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma AT singhswati expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma AT maniashutosh expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma |